^
    Apply
    Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer (K19017-004) (NCT05684731)
    Phase 1
    Tongji Hospital
    Not yet recruiting
    Last update posted :
    01/13/2023
    Initiation :
    02/01/2023
    Primary completion :
    06/01/2025
    Completion :
    06/01/2026
    MUC16
    |
    Avastin (bevacizumab) • cisplatin • carboplatin • albumin-bound paclitaxel • KM1